Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06549621

Cardiotoxicity of Carbon Monoxide in Patients Treated With Hyperbaric Oxygen Therapy

Status
Recruiting
Phase
Study type
Observational
Enrollment
66 (estimated)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers

Summary

Carbon monoxide poisoning is a frequent domestic accident and the leading cause of death from unintentionnal poisoning. Its toxicity is based on the CO binding to hemoglobin and myoglobin, inhibition of mitochondrial cytochrome oxidase, resulting in tissue hypoxia and reduced adenosine triphosphate synthesis and ischemia-reperfusion injury. This study aims to investigate the early and late cardiologic effects of CO in patients treated with hyperbaric oxygen (HBOT) for CO poisoning

Detailed description

This is a single-center retrospective study on health data. The methodology includes a collection of data on health and history data of patients treated by HBOT fo CO poisoning between 01/01/2015 and 31/12/2021 and carrying out a telephone interview of patients who have had early cardiovascular manifestations of CO poisoning. One month between the start of theses interviews, an information letter on the study is sent by post, giving the possibility of opposing it.

Conditions

Timeline

Start date
2022-07-25
Primary completion
2022-10-25
Completion
2024-10-25
First posted
2024-08-12
Last updated
2024-08-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06549621. Inclusion in this directory is not an endorsement.